Market Cap | ₹1,633Cr |
ROE | 14.45% |
P/E Ratio(TTM) | 28.48 |
EPS(TTM) | 0.61 |
P/B Ratio | 4.77 |
Dividend Yield | 0.00% |
Industry P/E | 35.33 |
Book Value | 3.64 |
Debt to Equity | 0.01 |
Face Value | 1 |
Parent Organisation | Syncom Formulations (india) |
Managing Director | Shri. Vijay Bankda |
NSE Symbol | SYNCOMF |
COMPANY | 52 WEEK | MARKET PRICE | P/E Ratio | |
---|---|---|---|---|
Torrent Pharmaceuticals | NA (0.00%) | 61.75 | ||
Gland Pharma | NA (0.00%) | 43.16 | ||
Ajanta Pharma | NA (0.00%) | 34.16 | ||
Eris Lifesciences | NA (0.00%) | 57.46 |